TY - JOUR
T1 - When continuous outcomes are measured using different scales
T2 - Guide for meta-analysis and interpretation
AU - Murad, Mohammad Hassan
AU - Wang, Zhen
AU - Chu, Haitao
AU - Lin, Lifeng
N1 - Funding Information:
Funding: This research did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sector. HC is supported in part by the National Library of Medicine (R21 LM012197, R21 LM012744), and the National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK106786). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to.
PY - 2019
Y1 - 2019
N2 - It is common to measure continuous outcomes using different scales (eg, quality of life, severity of anxiety or depression), therefore these outcomes need to be standardized before pooling in a meta-analysis. Common methods of standardization include using the standardized mean difference, the odds ratio derived from continuous data, the minimally important difference, and the ratio of means. Other ways of making data more meaningful to end users include transforming standardized effects back to original scales and transforming odds ratios to absolute effects using an assumed baseline risk.
AB - It is common to measure continuous outcomes using different scales (eg, quality of life, severity of anxiety or depression), therefore these outcomes need to be standardized before pooling in a meta-analysis. Common methods of standardization include using the standardized mean difference, the odds ratio derived from continuous data, the minimally important difference, and the ratio of means. Other ways of making data more meaningful to end users include transforming standardized effects back to original scales and transforming odds ratios to absolute effects using an assumed baseline risk.
UR - http://www.scopus.com/inward/record.url?scp=85060380492&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060380492&partnerID=8YFLogxK
U2 - 10.1136/bmj.k4817
DO - 10.1136/bmj.k4817
M3 - Article
C2 - 30670455
AN - SCOPUS:85060380492
SN - 0959-8146
VL - 364
JO - The BMJ
JF - The BMJ
M1 - k4817
ER -